ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,505,574 | +58.1% | 1,536,300 | +124.3% | 0.00% | +100.0% |
Q2 2023 | $952,194 | -30.1% | 685,032 | -20.1% | 0.00% | -50.0% |
Q1 2023 | $1,362,948 | -84.6% | 857,200 | -39.5% | 0.00% | -84.0% |
Q4 2022 | $8,821,680 | +21.4% | 1,416,000 | +30.6% | 0.02% | +19.0% |
Q3 2022 | $7,265,000 | +8447.1% | 1,084,300 | +7991.8% | 0.02% | – |
Q2 2022 | $85,000 | -96.0% | 13,400 | -77.1% | 0.00% | -100.0% |
Q3 2019 | $2,141,000 | -70.1% | 58,400 | -62.0% | 0.01% | -72.2% |
Q2 2019 | $7,155,000 | +164.0% | 153,800 | +127.9% | 0.02% | +157.1% |
Q1 2019 | $2,710,000 | +26.2% | 67,500 | +44.5% | 0.01% | +16.7% |
Q4 2018 | $2,148,000 | +39.4% | 46,700 | +119.2% | 0.01% | +50.0% |
Q1 2018 | $1,541,000 | -2.5% | 21,300 | -11.2% | 0.00% | 0.0% |
Q4 2017 | $1,580,000 | +112.9% | 24,000 | +62.2% | 0.00% | +100.0% |
Q3 2017 | $742,000 | -85.8% | 14,800 | -76.8% | 0.00% | -95.0% |
Q2 2015 | $5,213,000 | +151.8% | 63,759 | +185.2% | 0.04% | +150.0% |
Q1 2015 | $2,070,000 | – | 22,359 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |